Stay updated on T-VEC + Pembrolizumab in Sarcoma Clinical Trial

Sign up to get notified when there's something new on the T-VEC + Pembrolizumab in Sarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the T-VEC + Pembrolizumab in Sarcoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study content with an error screen. As a result, users cannot view the study overview, eligibility criteria, locations, or contacts.
    Difference
    18%
    Check dated 2026-09-23T01:11:10.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page's revision tag updated from v3.6.6 to v3.7.0. This indicates a new build of the page system, typically reflecting maintenance or minor fixes rather than changes to the study content.
    Difference
    0.1%
    Check dated 2026-09-16T00:06:59.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    The page revision label changed from v3.6.5 to v3.6.6, signaling a minor update to the page's versioning metadata.
    Difference
    0.1%
    Check dated 2026-09-01T19:23:39.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Revision badge updated from v3.6.4 to v3.6.5, indicating a newer version of the study protocol/plan linked on the page. This reflects an update to the document version associated with the study record.
    Difference
    0.1%
    Check dated 2026-08-11T18:55:06.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    The study documents now show revision v3.6.4, replacing the previous v3.6.3. This indicates an updated version of the protocol/SAP materials in the study package.
    Difference
    0.1%
    Check dated 2026-07-28T15:14:39.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    New Study Record Dates have been added to reflect the latest update (2026-07-17) and an estimated completion (2027-03), along with other recent submission timestamps (2026-06-18, 2026-06). Older dates (2025-10-29, 2026-03, 2025-10-15, 2025-07) have been removed, updating the record history.
    Difference
    0.3%
    Check dated 2026-07-21T11:51:09.000Z thumbnail image

Stay in the know with updates to T-VEC + Pembrolizumab in Sarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the T-VEC + Pembrolizumab in Sarcoma Clinical Trial page.